MedMen Enterprises Inc.
MMNFF · OTC
3/25/2023 | 12/24/2022 | 9/24/2022 | 6/25/2022 | |
|---|---|---|---|---|
| Revenue | $27,225 | $29,554 | $30,044 | $33,310 |
| % Growth | -7.9% | -1.6% | -9.8% | – |
| Cost of Goods Sold | $14,077 | $14,501 | $15,188 | $16,056 |
| Gross Profit | $13,148 | $15,053 | $14,856 | $17,253 |
| % Margin | 48.3% | 50.9% | 49.4% | 51.8% |
| R&D Expenses | $0 | $0 | $0 | $0 |
| G&A Expenses | $15,960 | $14,850 | $17,846 | $21,904 |
| SG&A Expenses | $16,538 | $15,401 | $18,290 | $22,486 |
| Sales & Mktg Exp. | $578 | $551 | $444 | $583 |
| Other Operating Expenses | $6,883 | $2,170 | $2,350 | $4,830 |
| Operating Expenses | $23,421 | $17,571 | $20,640 | $27,316 |
| Operating Income | -$10,273 | -$2,490 | -$5,783 | -$10,063 |
| % Margin | -37.7% | -8.4% | -19.2% | -30.2% |
| Other Income/Exp. Net | -$27,110 | -$8,231 | -$12,207 | -$96,918 |
| Pre-Tax Income | -$36,576 | -$14,025 | -$18,065 | -$107,726 |
| Tax Expense | -$5,367 | $1,061 | $2,194 | -$21,451 |
| Net Income | -$31,208 | -$15,086 | -$20,259 | -$86,275 |
| % Margin | -114.6% | -51% | -67.4% | -259% |
| EPS | -0.023 | -0.012 | -0.016 | -0.075 |
| % Growth | -100.9% | 25.6% | 79.1% | – |
| EPS Diluted | -0.023 | -0.012 | -0.016 | -0.075 |
| Weighted Avg Shares Out | 1,340,935 | 1,301,875 | 1,301,660 | 1,153,538 |
| Weighted Avg Shares Out Dil | 1,340,935 | 1,301,875 | 1,301,660 | 1,153,538 |
| Supplemental Information | – | – | – | – |
| Interest Income | $37 | $28 | $0 | $23 |
| Interest Expense | $11,640 | $11,231 | $11,635 | $4,630 |
| Depreciation & Amortization | $3,331 | $3,500 | $3,972 | $7,444 |
| EBITDA | -$6,942 | $1,009 | -$1,812 | -$95,831 |
| % Margin | -25.5% | 3.4% | -6% | -287.7% |